deoxypyridinoline has been researched along with c-peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, H; Kikuyama, M; Kurose, T; Maruyama, M; Nagamatsu, S; Seino, Y; Sugimoto, C; Suzuki, K; Takizawa, M; Ushikawa, K | 1 |
1 other study(ies) available for deoxypyridinoline and c-peptide
| Article | Year |
|---|---|
Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Topics: Acid Phosphatase; Amino Acids; Biomarkers; Bone Density; C-Peptide; Calcitriol; Calcium; Collagen; Collagen Type I; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Glycoproteins; Humans; Insulin; Isoenzymes; Magnesium; Male; Middle Aged; Osteocalcin; Osteoclasts; Osteoprotegerin; Parathyroid Hormone; Peptides; Phosphorus; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sex Factors; Tartrate-Resistant Acid Phosphatase | 2005 |